Cooper D N, Clayton J F
Haematology Department, King's College Hospital School of Medicine and Dentistry, London, UK.
Hum Genet. 1988 Apr;78(4):299-312. doi: 10.1007/BF00291724.
Recombinant DNA approaches to disease analysis may be as applicable to studies of disease association as they are to the analysis and diagnosis of single-gene defects. Population and/or family association analyses, using restriction fragment length polymorphisms around candidate genes as markers, have been employed to study conditions such as atherosclerosis and disease with an HLA-association. Progress made to date in disease-association studies using recombinant DNA methodology is reviewed, the rationale behind such studies is examined and associated problems and pitfalls discussed.
重组DNA技术在疾病分析中的应用,对于疾病关联性研究可能与对单基因缺陷的分析和诊断同样适用。利用候选基因周围的限制性片段长度多态性作为标记进行群体和/或家族关联性分析,已被用于研究诸如动脉粥样硬化以及与HLA相关的疾病等情况。本文回顾了迄今为止使用重组DNA方法在疾病关联性研究中取得的进展,探讨了此类研究背后的基本原理,并讨论了相关问题和陷阱。